Currently, all of CITIVA’s products are only available to registered patients in Jamaica, in accordance with their government regulations and restrictions. All listed product information is only applicable to our products formulated and available outside of the USA. As our products are licensed for sale in the US, we will update the product information accordingly. All products are formulated and made available according to specific state laws as applicable.
ACON is a high CBD/low THC (25:1) formula containing CITIVA’s proprietary cannabinoid and terpene blend.
Mode of Delivery: Tincture
- 25:1 CBD/THC Ratio
- 20 mg CBD/0.8 mg THC per dose
- Active Ingredients: CO2-Extracted CBD and THC
Observational and anecdotal data suggests that patients taking a high CBD/low THC ratio formulation may experience benefits which include*:
- Seizure reduction for certain types of epilepsy
- Improved neurological function
- Increased focus and concentration
- Decreased Inflammation